Results 31 to 40 of about 76,682 (163)

A Case Control Study of Nutrient Intake Deficiencies in Patients Taking Warfarin

open access: yesMarshall Journal of Medicine, 2015
Introduction We previously published the case of a woman taking warfarin who was found to have scurvy, a disease caused by a deficiency of vitamin C. This led us to hypothesize that patients taking warfarin who consume a diet limited in vitamin K rich
Philip Riley   +5 more
doaj   +1 more source

Profile and outcome of patients with Warfarin Toxicity admitted in a tertiary care hospital in Bhutan: a cross-sectional study investigators and institutions

open access: yesBMC Research Notes, 2023
Objective To study the profile, clinical presentation and outcome of hospital stay among patients admitted with warfarin toxicity at the Jigme Dorji Wangchuck National Referral Hospital, Bhutan.
Yeshey Penjore   +3 more
doaj   +1 more source

INTERACTIONS OF WARFARIN [PDF]

open access: yesBiomedical Papers, 2001
In this article, the author reviews and updates the basis of interactions with warfarin, illustrated with appropriate examples. The interactions with drugs, medicinal herbs and foods are summarised.
openaire   +2 more sources

Warfarin interactions: a letter to editor [PDF]

open access: yesPatient Safety and Quality Improvement Journal, 2019
Today, with the advances in the treatment of cardiovascular patients such as intravascular stents, cardiac valves and intraventricular pacing and heart transplantation, many patients require the use of anticoagulants such as warfarin, sprain, Plavix ...
Sayyed Majid Sadrzadeh   +4 more
doaj   +1 more source

Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population

open access: yesBMC Cardiovascular Disorders, 2019
Background Clinical trials have demonstrated that direct oral anticoagulants (DOACs) are at least non-inferior to warfarin in reducing the risk of stroke/systemic embolism (SE) among patients with non-valvular atrial fibrillation (NVAF), but the ...
Kiran Gupta   +7 more
doaj   +1 more source

Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism

open access: yesPatient Preference and Adherence, 2010
Patrick P Kneeland, Margaret C FangThe University of California, San Francisco Division of Hospital Medicine, San Francisco, CA, USAAbstract: Warfarin therapy reduces morbidity and mortality related to thromboembolism. Yet adherence to long-term warfarin
Patrick P Kneeland, Margaret C Fang
doaj  

ОЦЕНКА ТЕРАПЕВТИЧЕСКОЙ ЭФФЕКТИВНОСТИ ВАРФАРИНА ПРОИЗВОДСТВА ЗАО «КАНОНФАРМА ПРАДАКШЕН» (РОССИЯ)

open access: yesАрхивъ внутренней медицины, 2014
Warfarin by «Kanonpharma production» (Russia) and original Warfarin have the similar safety and tolerability. We need some increase of dose of Warfarin by «Kanonpharma production» to reach target rate of INR, then in case of original Warfarin usage.
М. В. Хруслов   +1 more
doaj   +1 more source

Simultaneous Effect of Vitamin C and Warfarin on Coagulation Pathways of Rats

open access: yesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, 2009
Introduction: The aim of the present study was to assess variations in coagulating pathways after simultaneous administration of warfarin and vitamin C. Methods: A total of 50 Wistar rats were selected.
S Nazifi, A Khoshvaghti, M Kazemi
doaj  

Warfarin and Flavonoids Do Not Share the Same Binding Region in Binding to the IIA Subdomain of Human Serum Albumin

open access: yesMolecules, 2017
Human serum albumin (HSA) binds a variety of xenobiotics, including flavonoids and warfarin. The binding of another ligand to the IIA binding site on HSA can cause warfarin displacement and potentially the elevation of its free concentration in blood ...
Hrvoje Rimac   +4 more
doaj   +1 more source

Bound to bleed: How altered albumin binding may dictate warfarin treatment outcome

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2019
Although non-vitamin-K anticoagulants are now the preferred option for stroke prevention in atrial fibrillation (AF), warfarin is still used in a significant number of patients.
Anke C. Fender, Dobromir Dobrev
doaj   +1 more source

Home - About - Disclaimer - Privacy